tweenvest

Retension Pharmaceuticals, Inc. (NasdaqCM: RTSN)

Health Care · Pharmaceuticals · US

$12.27

+0.16% today · +16.5% 1Y

Public summary
A free snapshot of Retension Pharmaceuticals, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Retension Pharmaceuticals, Inc. (NasdaqCM: RTSN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $102.23M and employs 12 people.

Over the last twelve months the share price has gained 16.5%, trading between 9.66 and 18.64.

Tweenvest scores Retension Pharmaceuticals, Inc. across four factors: quality 51/100, value 100/100. Its strongest factor is value.

RTSN price history

Oct 9, 2026 · 10.53Weekly closes 10.53 – 15.25Nov 13, 2026 · 12.27

Key figures

Market cap
$102.23M
Revenue (TTM)
—
P/E
-8.56
EPS
-14.81
Dividend yield
—
Beta (5Y)
—
52-week high
$18.64
52-week low
$9.66
Avg volume (3M)
—
Shares outstanding
8.33M
Employees
12
Next earnings
—

About Retension Pharmaceuticals, Inc.

Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension. The company was founded by Eric Keller and Paul Sweetnam in 2023 and is headquartered in Falls Church, VA.

ISIN
US76135H1005
Founded
2023
Listed since
Oct 9, 2026
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Asiatic Laboratories LimitedDSE: ASIATICLAB$104.89MTk107.30+2.88%
Journey Medical CorporationNasdaqCM: DERM$104.15M$3.69-5.38%
Organigram Global Inc.TSX: OGI$102.49MCA$1.04-11.86%
Semnur Pharmaceuticals, Inc.OTCPK: SMNR$102.32M$0.47+42.42%
Curatis Holding AGSWX: CURN$101.48MCHF16.00-4.76%
LENZ Therapeutics, Inc.NasdaqGS: LENZ$100.86M$3.21-7.76%
Themis Medicare LimitedBSE: 530199$99.14MRs101.50-0.61%
The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding CompanyASE: JPHM$98.68MJD1.540.00%

Browse every Pharmaceuticals company →